(Q40441770)

20 September 2017

1 reference

title

Rimantadine: a clinical perspective (English)

1 reference

20 September 2017

S M Wintermeyer

1

1 reference

PubMed ID

7606077

20 September 2017

M C Nahata

series ordinal

2

1 reference

PubMed ID

7606077

20 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

Annals of Pharmacotherapy

20 September 2017

1 reference

20 September 2017

29

1 reference

20 September 2017

299-310

1 reference

20 September 2017

3

1 reference

Study of rimantadine in the USSR: a review of the literature

20 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Combinations of antiviral agents for treatment of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Antiviral drugs for common respiratory diseases. What's here, what's to come.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Antiviral agents: action and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Antiviral chemotherapy and chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Prophylaxis and treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Plaque inhibition assay for drug susceptibility testing of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Influenza virus uncoating in infected cells and effect of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Economic impact of influenza. The individual's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Pharmacokinetics of a single dose of rimantadine in young adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Rimantadine pharmacokinetics after single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Multiple-dose pharmacokinetics of rimantadine in elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Synthesis and antiviral activity of metabolites of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Studies on the antiviral activity of amantadine hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Implications of viral resistance to amantadine in control of influenza A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Prevention of nosocomial influenza infection with Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Safety and pharmacokinetics of rimantadine small-particle aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Properties of antiviral agents. 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Amantadine hydrochloride. Analysis of data related to its proposed use for prevention of A2 influenza virus disease in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Effect of rimantadine on cytotoxic T lymphocyte responses and immunity to reinfection in mice infected with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

Effect of cimetidine on the disposition of rimantadine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900312

10.1177/106002809502900312

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7606077